1. Неонатология: национальное руководство: в 2 т./под ред. Н.Н. Володина, Д.Н. Дегтярева. - ГОЭТАР-Медиа. 2023.

2. Alan T. Nurden and Paquita Nurden Inherited thrombocytopenias: history, advances and perspectives Haematologica 2020 Volume 105(8): 2004 - 2019.

3. Baer, V. L., Lambert, D. K., Henry, E., & Christensen, R. D. (2009). Severe Thrombocytopenia in the NICU. PEDIATRICS, 124(6), e1095 - e1100. doi: 10.1542/peds.2009-0582.

4. Ram R. Kalagiri, SaiaraChoudhury, Timothy Carder, Vinayak Govande, Madhava R. Beeram, Nasir Uddin, Neonatal Thrombocytopenia as a Consequence of Maternal Preeclampsia Am J Perinatol Rep 2016; 6: e42 - e47.

5. Donato H. Neonatal thrombocytopenia: A review. I. Definitions, differential diagnosis, causes, immune thrombocytopenias. Arch Argent Pediatr 2021; 119(3): e202 - e214.

6. Simon J. Stanworth and Andrew D. Mumford How I diagnose and treat neonatal thrombocytopenia. Blood. 2686 1 JUNE 2023 | VOLUME 141, NUMBER 22. p 2685 - 2697.

7. Roberts I, Chakravorty S. Thrombocytopenia in the newborn. In: Platelets. 4th Ed. Academic Press; 2019: 813 - 831.

8. Mishra S, Jaiswar S, Saad S, et al. Platelet indices as a predictive marker in neonatal sepsis and respiratory distress in preterm prelabor rupture of membranes. Int J Hematol. 2021; 113(2): 199 - 206.

9. Boskabadi H, Mafinezhad S, Bagher F, Bozorgnia Y. Incidence of Thrombocytopenia in Idiopathic Hyperbilirubinemic Newborns. OA Maced J Med Sci. 2014 Jun 15; 2(2): 261 - 264. http://dx.doi.org/oamjms.2014.043.

10. EzgiUlusoy, , NurayDuman, Abdullah Kumral, , Hale , Thrombocytopenia in neonates: causes and outcomes Ann Hematol (2013) 92: 961 - 967 DOI 10.1007/s00277-013-1726-0.

11. Zdravic, D., Yougbare, I., Vadasz, B., Li, C., Marshall, A. H., Chen, P., Ni, H. (2016). Fetal and neonatal alloimmune thrombocytopenia. Seminars in Fetal and Neonatal Medicine, 21(1), 19 - 27. doi: 10.1016/j.siny.2015.12.00.

12. Василевский И.В. Вторичные (симптоматические) тромбоцитопении у детей и подростков/И.В. Василевский//Медицинская панорама. - 2009. - N 4. - С. 5 - 10).

13. Sola-Visner M, Sallmon H, Brown R. New insights into the mechanisms of nonimmune thrombocytopenia in neonates. Seminars in Perinatology. 2009; 33: 43.

14. Arnold DA. Drug-induced immune thrombocytopenia. UpToDate. 2020. Available from: https://www.uptodate.com/contents/drug-induced-immunethrombocytopenia).

15. Reese JA, Nguyen LP, Buchanan GR, et al. Drug-induced thrombocytopenia in children. Pediatric Blood & Cancer. 2013; 60: 1975).

16. Mella M.T., Eddleman K.A. Neonatal alloimmune thrombocytopenia//International Journal of Clinical Transfusion Medicine. 8 June 2015 Volume 2015: 3 Pages 29 - 40.

17. Goel R, Josephson CD. Recent advances in transfusions in neonates/infants. F1000Res. 2018; 7; F1000 Faculty Rev-609 Faculty Rev-609.

18. Neonatal Hematology, Pathogenesis, Diagnosis, and Management of Hematologic Problems, 3rd edition, ed. Pedro A. de , Eric J. Werner, Robert D. Christensen, and Martha C. Sola-Visner. Published by Cambridge University Press. Cambridge University Press 2021.

19. Roberts I., Murray N.A. Neonatal thrombocytopenia: causes and management. Arch Dis Child Fetal Neonatal Ed. 2003; 88: 359 - 64. Roberts I.A.G

20. Chakravotny S. Thrombocytopenia in the newborn. Platelets. (Michelson AD, editor). Amsterdam, Boston, Heidelberg et al. Elsivier.: Academic Press. 2013: 929 - 52.

21. Webert K.E., Mittal R., Sigouin C.A., et al. retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood. 2003; 102: 4306 - 11.

22. Koyama S., Tomimatsu T., Kanagawa T., et al. Reliable predictors of neonatal immune thrombocytopenia in pregnant women with idiopathic thrombocytopenic purpura. Am. J. Hematol. 2012; 87: 15 - 21

23. Beiner ME, Simchen MJ, Sivan E, Chetrit A, Kuint J, Schiff E. Risk factors for neonatal thrombocytopenia in preterm infants. Am J Perinatol. 2003; 20(1): 49 - 54. 20.

24. Kush ML, Gortner L, Harman CR, Baschat AA. Sustained hematological consequences in the first week of neonatal life secondary to placental dysfunction. Early Hum Dev. 2006; 82(1): 67 - 72.

25. Murray NA, Roberts IA. Circulating megakaryocytes and their progenitors in early thrombocytopenia in preterm neonates. Pediatr Res. 1996; 40(1): 112 - 119.].

26. Rodeghiero F., Stasi R., Gernsheimer T., et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009113: 2386 - 93.

27. Veneri D., Franchini M., Randon F., et al. Thrombocytopenias: a clinical point of view. Blood Transfus. 2009; 7: 75 - 85.

28. Psaila B., Bussel J.B. Immune thrombocytopenia (ITP). Platelets. (Michelson AD, ed.). Amsterdam, Boston, Heidelberg et al: Academic Press, Elsevier Inc. 2013: 819 - 33].

29. J. Neonatal thrombocytopenia: a common clinical problem. Paediatrics Today 2015; 11(2): 115 - 125.

30. Mehta P, Vasa R, Neumann L, Karpatkin M. Thrombocytopenia in the high-risk infant. The Journal of Pediatrics. 1980; 97: 791 - 794.

31. Muthukumar P, Venkatesh V, Curley A et al. Severe thrombocytopenia and patterns of bleeding in neonates: results from a prospective observational study and implications for use of platelet transfusions. TransfusMed. 2012 Oct; 22(5): 338 - 43. doi: 10.1111/j.1365-3148.2012.01171

32. Ting Peng, Yuanyuan Shan, Peng Zhang et al. Bleeding in neonates with severe thrombocytopenia: a retrospective cohort study. BMC Pediatrics (2022) 22: 730 https://doi.org/10.1186/s12887-022-03802-4.

33. Thrombocytopenia in the Newborn Kerry Morrone, Downloaded from http://neoreviews.aappublications.org/ by guest on January 19, 2019.

34. Christensen RD. Platelet transfusion in the neonatal intensive care unit: Benefits, risks, alternatives. Neonatology. 2011; 100: 311 - 318]

35. Hasan R., Saifee N.H. Benefits of lower neonatal platelet transfusion thresholds. Transfusion. 2021 Jun; 61(6): 1672 - 1675. doi: 10.1111/trf.16386

36. Murphy M. F., Simon I. R., Stanworth J. et al. Prospective, Observational Study of Outcomes in Neonates With Severe Thrombocytopenia. Pediatrics 2009; 124; e826.

37. Botero P. J, Reese JA, George JN, McIntosh JJ. Severe thrombocytopenia and microangiopathic hemolytic anaemia in pregnancy. A guide for the consulting hematologist. Am J Hematol, (2021) 96, 1655 - 1665.

38. Christensen R. D., Baer V.L., Henry E. et al. Thrombocytopenia in Small for Gestational Age Infants Pediatrics. 2015 August; 136(2): e361 - e370. doi: 10.1542/peds.2014-4182,

39. Fustolo-Gunnink S. F., Vlug R. D., Smits-Wintjens V. E. H. et al. Early-Onset Thrombocytopenia in Small-For-Gestational-Age Neonates: A Retrospective Cohort Study. (2016). PLOS ONE, 11(5), e0154853. doi: 10.1371/journal.pone.0154853]

40. Christensen R. D., Baer V. L., &Yaish, H. M. Thrombocytopenia in late preterm and term neonates after perinatal asphyxia. Transfusion, (2014), 55(1), 187 - 196. doi: 10.1111/trf.12777.

41. Haley K.M. Neonatal venous thromboembolism. Front. Pediatr. 2017; 5: 136. doi: 10.3389/fped.2017.00136. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

42. Bhat R., Kumar R., Kwon S., Murthy K., Liem R.I. Risk Factors for Neonatal Venous and Arterial Thromboembolism in the Neonatal Intensive Care Unit-A Case Control Study. J. Pediatr. 2018; 195: 28 - 32. doi: 10.1016/j.jpeds.2017.12.015. [PubMed] [CrossRef] [Google Scholar]

43. van Ommen C.H., Heijboer H., H.R., Hirasing R.A., Heijmans H.S., Peters M. Venous thromboembolism in childhood: A prospective two-year registry in The Netherlands. J. Pediatr. 2001; 139: 676 - 681. doi: 10.1067/mpd.2001.118192. [PubMed] [CrossRef] [Google Scholar]

44. Chalmers E.A. Neonatal thrombosis. J. Clin. Pathol. 2000; 53: 419 - 423. doi: 10.1136/jcp.53.6.419. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

45. Kauzar M., Salahuddin I., Naveed A. Examine the Frequency of Thrombocytopenia in Newborns with Neonatal Sepsis P J M H S Vol. 14, NO. 2, APR - JUN 2020658

46. Kaplan C. Foetal and neonatal alloimmune thrombocytopaenia Orphanet Journal of Rare Diseases 2006, 1: 39

47. Chiurazzi F, Villa MR, Rotoli B. Transplacental transmission of EDTA dependent pseudothrombocytopenia. Haematologica, (1999) 84, 664 - 665

48. Ohno N, Kobayashi M, Hayakawa S, Utsonomiya A and Karakawa S (2012) Transient pseudothrombocytopenia in a neonate: transmission of a maternal EDTA dependent anticoagulant. Platelets, 23, 399 - 400;

49. Christensen R, Sola MC, Rimsza LM, McMahan MJ and Calhoun DA (2004) Pseudothrombocytopenia in a preterm neonate. Pediatrics, 114, 273 - 275.]

50. Ault KA, Knowles C. In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation. Exp Hematol 1995; 23(9): 996 - 1001

51. Ault KA, Rinder HM, Mitchell J, et al. The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis. Am J Clin Path 1992; 98: 637 - 46.

52. Peterec SM, Brennan SA, Rinder HM, Wnek JL, Beardsley DS. Reticulated platelet values in normal and thrombocytopenic neonates. J Pediatr 1996; 129(2): 269 - 74.

53. MacQueen BC, Christensen RD, Henry E, et al. The immature platelet fraction: Creating neonatal reference intervals and using these to categorize neonatal thrombocytopenias. J Perinatol 2017; 37 (7): 834 - 8

54. Хаспекова С.Г., Шустова О.Н., Головкина Л.Л., Мазуров А.В. Диагностические маркеры и предикторы неонатальной иммунной тромбоцитопении//Гематология и трансфузиология. - 2019. - Т. 64. - N 2. - С. 198 - 210.

55. Sola MC, Slayton WB, Rimsza LM, et al. A neonate with severe hrombocytopenia and radio-ulnar synostosis. J Perinatol 2004; 24(8): 528 - 30.

56. Tighe P, Rimsza LM, Christensen RD, Lew J, Sola MC. Severe thrombocytopenia in a neonate with congenital HIV infection. J Pediatr 2005; 146 (3): 408 - 13.

57. Saxonhouse MA, Manco-Johnson MJ. The evaluation and management of neonatal coagulation disorders. Semin Perinatol 2009; 33 (1): 52 - 65.

58. Josephson CD, Su LL, Christensen RD, et al. Platelet transfusion practices among neonatologists in the United States and Canada: Results of a survey. Pediatrics 2009; 123(1): 278 - 85.

59. Cremer M, Sola-Visner M, Roll S, et al. Platelet transfusions in neonates: Practices in the United States vary significantly from those in Austria, Germany, and Switzerland. Transfusion 2011; 51 (12): 2634 - 41.

60. Kahn DJ, Richardson DK, Billett HH. Inter-NICUvariation in rates and management of thrombocytopenia among very low birth-weight infants. J Perinatol 2003; 23(4): 312 - 16.

61. Del Vecchio A, Sola MC, Theriaque DW, et al. Platelet transfusions in the neonatal intensive care unit: Factors predicting which patients will require multiple transfusions. Transfusion 2001; 41 (6): 803 - 8.

62. Garcia MG, Duenas E, Sola MC, et al. Epidemiologic and outcome studies of patients who received platelet transfusions in the neonatal intensive care unit. J Perinatol 2001; 21(7): 415 - 20.

63. Murray NA, Howarth LJ, McCloy MP, Letsky EA, Roberts IA. Platelet transfusion in the management of severe thrombocytopenia in neonatal intensive care unit patients. Transfus Med 2002; 12(1): 35 - 41.]

64. Ribeiro H.S., A., Vieira R. J., Soares P. Platelet transfusions in preterm infants: current concepts and controversies - a systematic review and meta-analysis Received: 2 April 2023/Revised: 10 May 2023/Accepted: 17 May 2023/Published online: 1 June 2023.

65. Fustolo-Gunnink S.F., Huisman E.J., van der Bom J.G. et. Al. Are thrombocytopenia and platelet transfusions associated with major bleeding in preterm neonates? A systematic review. Blood Reviews Volume 36, July 2019, Pages 1 - 2.

66. Sparger K. A., Assmann S.F., Granger S. Platelet Transfusion Practices Among Very-Low-Birth-Weight Infants. JAMA Pediatr. 2016 Jul 1; 170(7): 687 - 694. doi: 10.1001/jamapediatrics.2016.0507].

67. Sparger K., Deschmann E., Sola-Visner M. Platelet Transfusions in the ICU.ClinPerinatol. 2015 September; 42(3): 613 - 623. doi: 10.1016/j.clp.2015.04.009.

68. Provan D, Stasi R, Newland AC, Blanchette VS, BoltonMaggs P, Bussel J et al. (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood, 115, 168 - 186.

69. van der Lugt NM, van Kampen A, Walther FJ, Brand A and Lopriore E (2013) Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpura. Vox Sang, 105, 236 - 243.

70. Roberts I, Stanworth S, Murray NA Thrombocytopenia in the neonate. Blood Rev, 2008, 22, 173 - 186.

71. Румянцев А.Г. Основные свойства внутривенных иммуноглобулинов и показания к их применению//Вопросы гематологии/онкологии и иммунопатологии в педиатрии. - 2011. - Т. 10. - N. 2. - С. 39 - 50

72. Третьякова О.С. и др. Иммунная тромбоцитопения у детей: стероидные гормоны или внутривенные иммуноглобулины?//Педиатрия. Восточная Европа. - 2015. - N. 2. - С. 130 - 137.

73. Масчан А.А., Румянцев А.Г., Ковалева Л.Г., Афанасьев Б.В., Поспелова Т.И., Зарицкий А.Ю. и др. Рекомендации Российского совета экспертов по диагностике и лечению больных первичной иммунной тробоцитопенией. Онкогематология. 2010; 3: 36 - 45.

74. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br. J. Haematol. 2003; 120(4): 574 - 96;

75. Меликян А.Л. и др. Национальные клинические рекомендации по диагностике и лечению первичной иммунной тромбоцитопении (идиопатической тромбоцитопенической пурпуры) у взрослых//Гематология и трансфузиология. - 2015. - Т. 60. - N. 1. - С. 44 - 56].

76. Ming JY, Kathryn W, Kendall S. Maternal and Neonatal Idiopathic Thrombocytopenic Purpura. SOJ Pedia Clin Neonato. 2020; 1(1): 1 - 3. DOI: 10.53902/SOJPCN.2020.01.000504

77. Yamada H, Kato EH, Kobashi G, et al. Passive immune thrombocytopenia in neonates of mothers with idiopathic thrombocytopenic purpura: incidence and risk factors. Semin ThrombHemost. 1999; 25(5): 491 - 496.

78. Шабалов Н.П. Неонатология: учебное пособие в 2 т. ГОЭТАР-Медиа, 2020 - Т. 2.

79. Gomella T.L., Cunningham M.D. Gomella's Neonatology, 8^th Edition, 2020, p. 1472.

80. Baker JM, Shehata N, Bussel J, Murphy MF, Greinacher A, Bakchoul T et al. (2019) Postnatal intervention for the treatment of FNAIT: a systematic review. J Perinatol, 39, 1329 - 1339.

81. Lieberman L, Greinacher A, Murphy MF, Bussel J, Bakchoul T, Corke S et al. (2019) Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidencebased practice, an international approach. Br J Haematol, 185, 549 - 562.

82. De Vos TW, Winkelhorst D, de Haas M, Lopriore E and Oepkes D (2020) Epidemiology and management of fetal and neonatal alloimmune thrombocytopenia. TransfusApher Sci, 59, 102704.

83. Sola-Visner M., Leeman K. T., Stanworth S.J. Neonatal platelet transfusions: New evidence and the challenges of translating evidence-based recommendations into clinical practice J ThrombHaemost. 2022; 20: 556 - 564.

84. Ferrer-Marin F, Chavda C, Lampa M, Michelson AD, Frelinger AL 3rd, Sola-Visner M. Effects of in vitro adult platelet transfusions on neonatal hemostasis. JThrombHaemost. 2011 May; 9(5): 1020 - 1028.

85. Hauschner H., Rosenberg N., Seligsohn U. et al. Persistent neonatal thrombocytopenia can be caused by IgA antiplatelet antibodies in breast milk of immune thrombocytopenic mothers. Blood. 2015; 126(5): 661 - 664

86. Winkelhorst D., Murphy M.F., Greinacher A. et al. Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review. Blood. 2017; 129 (11): 1538 - 1547.

87. Rayment R., Brunskill S.J., Soothill P.W. et al. Antenatal interventions for fetomaternal alloimmune thrombocytopenia. Cochrane Database Syst. Rev. 2011.

88. Pacheco L.D., Berkowitz R.L., Moise K.J. Jr. et al. Fetal and neonatal alloimmune thrombocytopenia: a management algorithm based on risk stratification. Obstet. Gynecol. 2011; 118 (5): 1157 - 1163.

89. Van den Akker E.S., Oepkes D., Lopriore E. et al. Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective. BJOG. 2007; 114 (4): 469 - 473.

90. Althaus J., Weir E.G., Askin F. et al. Chronic villitis in untreated neonatal alloimmune thrombocytopenia: an etiology for severe early intrauterine growth restriction and the effect of intravenous immunoglobulin therapy. Am. J. Obstet. Gynecol. 2005; 193 (3 Pt. 2): 1100 - 1104.

91. Bussel J.B., Berkowitz R.L., Hung C. et al. Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus. Am. J. Obstet. Gynecol. 2010; 203 (2): 135. e1 - 14.

92. Berger M. Adverse effects of IgG therapy. J. Allergy Clin. Immunol. Pract. 2013; 1 (6): 558 - 566.

93. Боровкова Е.И., Романовская В.В., Коблова А.А., Тимощук Е.Д. Неонатальная аллоиммунная тромбоцитопения: сложности диагностики и терапии. Актуальные вопросы женского здоровья. 2022; (1): 26 - 31. DOI 10.46393/2713122X_2022_1_26

94. Клинические рекомендации МЗ РФ. Идиопатическая тромбоцитопеническая пурпура (ИТП) у взрослых. 2021.

95. Khaspekova S. G., Shustova O. N., Golubeva N. V., Naimushin Y. A., Larina L.E., Mazurov A. V. Circulating antiplatelet antibodies in pregnant women with immune thrombocytopenic purpura as predictors of thrombocytopenia in the newborns//Platelets. - 2019. - N 7 - P 1 - 5.

96. Salamon DJ, Nusbacher J, Stroupe T, et al. Red cell and platelet-bound IgG penicillin antibodies in a patient with thrombocytopenia, Transfusion 1984; 24: 395 - 8. 8.

97. Murphy MF, Riordan T, Minchinton RM et al. Demonstration of an immune mediated mechanism of penicillin-induced neutropenia and thrombocytopenia. BrJHaematol 1983; 55: 135 - 60.9.

98. Parker CW. Hapten immunology and allergic reactions in humans. Arthr Rheum 1981; 24: 1024 - 36.

99. Aster RH. Drug-induced immune thrombocytopenia: an overview of pathogenesis. Semin Hematol 1999; 36(1): 2 - 6.].

100. Cartis BR. Drug-induced immune thrombocytopenia: incidence, clinical features, laboratory testing, and pathogenic mechanisms. Immunohematology 2014; 30: 55 - 65,

101. Bougie D, Aster R. Immune thrombocytopenia resulting from sensitivity to metabolites of naproxen and acetaminophen. Blood 2001; 97: 3846 - 50.].

102. von dem Borne AE, Pegels JG, van der Stadt RJ, et al. Thrombocytopenia associated with gold therapy: a drug-induced autoimmune disease? Br J Haematol 1986; 63: 509 - 16.].

103. Aster RH. Immune thrombocytopenia caused by glycoprotein IIb/IIIa inhibitors. Chest 2005; 127(2): 535 - 98].

104. Wade EE, Rebuck JA, Healy MA, et al. H2 Antagonist induced thrombocytopenia: is this real phenomenon? Intens Cite Med 2002; 28: 459 - 65

105. Остроумова О.Д., Кравченко Е.В., Кочетков А.И. Лекарственно-индуцированная тромбоцитопения//Клиническая фармакология и терапия. - 2019. - Т. 28. - N. 4. - С. 56 - 64.

106. Manual of pediatric hematology and oncology/Philip Lanzkowsky 2005.

107. Van den Bemt PMLA, Meyboom RHB. Drug-induced immune thrombocytopenia. Drug Saf 2004; 27: 1243 - 52.

108. George JN, Raskob GE, Shah SR et al. Drug-induced thrombocytopenia a systematic review of published case reports. Ann Intern Med 1998; 129: 886 - 90.

109. AL-Nouri ZI, George JN. Drug-induced thrombocytopenia. An updated systematic review, 2012. Drug Saf 2012; 35: 693 - 4.

110. Visentin GP, Newman PJ, Aster RH. Characteristics of quinine and quinidineinduced antibodies specific for platelet glycoproteins IIb and Illa. Blood 1991; 77: 2668 - 76.

111. Conley EL, Coley KC, Pollock BG, et al. Prevalence and risk of thrombocytopenia with valproic acid: experience at a psychiatric teaching hospital. Pharmacotherapy 2001; 21: 1325 - 30

112. Mailman JF, Stigant C, Martinusen D. Moxifloxacin-induced immune-mediated thrombocytopenia in a chronic kidney disease patient receiving hemodialysis. Annal Pharmacother 2014; 48: 919 - 22.

113. Ranieri MM, Bradley EF, Simon AB. Meloxicam-induced thrombocytopenia. Pharmacotherapy. 2014; 34: e14 - 17.

114. Agipakis DI, Massa EV. A case of fenofibrate-induced immune thrombocytopenia: first report. P R Health Sci J 2015; 34: 170 - 3

115. Tan MW, Sklar GE. Pentoxflline-induced thrombocytopenia: a case report. J PharmPract 2015; 28: 572 - 6.

116. Del Vecchio A. Evaluation and management of thrombocytopenic neonates in the intensive care unit. Early Human Development. 2014; 90(S2): 551 - 555

117. Bernhard Resch Thrombocytopenia in Neonates DOI: 10.5772/intechopen.92857

118. SE Wiedmeier, E Henry, MC Sola-Visner and RD Christensen; Journal of Perinatology (2009) 29, 130 - 136

119. Curley A, Stanworth SJ, Willoughby K, Fustolo-Gunnink SF, Venkatesh V, Hudson C, Deary A, Hodge R, Hopkins V, Lopez Santamaria B, Mora A, Llewelyn C, D'Amore A, Khan R, Onland W, Lopriore E, Fijnvandraat K, New H, Clarke P, Watts T; PlaNeT2 MATISSE Collaborators. Randomized Trial of Platelet-Transfusion Thresholds in Neonates. N Engl J Med. 2019 Jan 17; 380(3): 242 - 251. doi: 10.1056/NEJMoa1807320.

120. de Vos TW, Winkelhorst D, de Haas M, Lopriore E, Oepkes D. Epidemiology and management of fetal and neonatal alloimmune thrombocytopenia. TransfusApher Sci. 2020 Feb; 59(1): 102704. doi: 10.1016/j.transci.2019.102704.

121. de Vos TW, Winkelhorst D, V, van der Bom JG, Canals C, Caram-Deelder C, Deschmann E, Haysom HE, Hverven HBC, LozarKrivec J, McQuilten ZK, E, N, Oepkes D, Porcelijn L, van der Schoot CE, Saxonhouse M, Sola-Visner M, Tiblad E, Tiller H, Wood EM, Young V, M, de Haas M, Lopriore E. Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study. Lancet Haematol. 2022 Nov; 9(11): e844 - e853.

122. Winkelhorst D, Oostweegel M, Porcelijn L, Middelburg RA, Zwaginga JJ, Oepkes D, van der Bom JG, de Haas M, Lopriore E. Treatment and outcomes of fetal/neonatal alloimmune thrombocytopenia: a nationwide cohort study in newly detected cases. Br J Haematol. 2019 Mar; 184(6): 1026 - 1029. doi: 10.1111/bjh.15216

123. New HV, Berryman J, Bolton-Maggs PH, Cantwell C, Chalmers EA, Davies T, Gottstein R, Kelleher A, Kumar S, Morley SL, Stanworth SJ; British Committee for Standards in Haematology. Guidelines on transfusion for fetuses, neonates and older children. Br J Haematol. 2016 Dec 175(5): 784 - 828. doi: 10.1111/bjh.14233.

124. Sparger K, Deschmann E, Sola-Visner M. Platelet Transfusions in the Neonatal Intensive Care Unit. ClinPerinatol. 2015 Sep; 42(3): 613 - 23. doi: 10.1016/j.clp.2015.04.009.

125. Batton E, Leibel SL. Immune-Mediated Neonatal Thrombocytopenia. Neoreviews. 2022 Jul 1; 23(7): e462 - e471.

126. Venkatesh V, Curley A, Khan R, et al. A novel approach to standardised recording of bleeding in a high risk neonatal population. Arch Dis Child Fetal Neonatal Ed. 2013; 98(3): F260 - F263. doi: 10.1136/archdischild-2012-302443

127. Неонатальная гематология: практическое руководство/И. Робертс, Б.Дж. Бейн; пер. с англ. под ред. Е.Н. Балашовой, - Москва: ГЭОТАР-Медиа, 2024. - 248 с.

128. Sokou R, Gounari EA, Lianou A, Tsantes AG, Piovani D, Bonovas S, Iacovidou N, Tsantes AE. Rethinking Platelet and Plasma Transfusion Strategies for Neonates: Evidence, Guidelines, and Unanswered Questions. Semin Thromb Hemost. 2026 Feb; 52(1): 56 - 79.

129. Beltrami-Moreira M, Sharma A, Bussel JB. Immune thrombocytopenia and pregnancy: challenges and opportunities in diagnosis and management. Expert Rev Hematol. 2024 Sep; 17(9): 595 - 607.

130. Winkelhorst D, Kamphuis MM, Steggerda SJ, Rijken M, Oepkes D, Lopriore E, van Klink JMM. Perinatal Outcome and Long-Term Neurodevelopment after Intracranial Haemorrhage due to Fetal and Neonatal Alloimmune Thrombocytopenia. Fetal Diagn Ther. 2019; 45(3): 184 - 191.

131. Mohila CA, Kubicka ZJ, Ornvold KT, Harris BT. Cerebellar loss and brain-stem atrophy associated with neonatal alloimmune thrombocytopenia in a discordant twin. Pediatr Dev Pathol. 2010 Jan-Feb; 13(1): 55 - 62.

132. Kaplan C. Immune thrombocytopenia in the foetus and the newborn: diagnosis and therapy. Transfus Clin Biol. 2001 Jun; 8(3): 311 - 4.

133. Кривошеина Л., Кольцова С.Ю., Рябцев А.А. [и др.] Неонатальные тромбоцитопении (обзор литературы и клинические наблюдения)/Е.//Верхневолжский медицинский журнал. - 2021. - Т. 20, N 4. - С. 23 - 30.